-
-
- Oct 2/26
Engineered AAV capsid reaches the outer retina through a simple eye injection - Oct 1/26
Silencing NOTCH1 makes leukemia cells vulnerable to CD19 CAR-T attack - Oct 1/26
Taming the cytokine storm: How doctors are making CAR T-cell therapy safer - Oct 1/26
New mechanism of antiviral immunity discovered - Sep 30/26
Engineered T cells targeting Hepatitis B antigen show glimmer of benefit in advanced liver cancer - Sep 30/26
CAR-T therapy may cost less than stem cell transplants beyond the price tag, German data suggest - Sep 30/26
Masked AAV vectors switch on gene delivery only where disease signals strike - Sep 30/26
Engineered immune cells push melanoma therapy into a new era - Sep 30/26
Rice engineer brings ‘surgineering’ mindset to future of medicine - Sep 30/26
UB researchers grow salivary mini organs from pluripotent stem cells - Sep 28/26
Regenerative medicine needs more than stem cells - Sep 28/26
Study reveals why some patients reject off-the-shelf CAR T cells - Sep 28/26
Speaker: CAR T-cell trial deaths add ‘sobriety’ to discussions with autoimmune patients - Sep 28/26
AI identifies signs of aging in blood stem cells - Sep 28/26
China now leads the world in trials for next-gen CAR-T therapies - Sep 27/26
Some pancreatic cells are just one genetic tweak away from treating diabetes - Sep 27/26
Weekly reads: $100B NIH budget dream, Sholto David on YouTube, Jun Takahashi award, Muse cell developments - Sep 25/26
New study opens doors for precise control of cells using light - Sep 24/26
UCLA scientists receive CIRM grants to advance stem cell-based treatments for vision loss, infertility - Sep 24/26
Stanford researchers discover that the human brain may be two separate organs fused together - Sep 23/26
From CAR-T cells to cancer organoids: The technologies set to transform clinical oncology - Sep 23/26
Fatal inflammatory risks associated with CAR T-cell therapy - Sep 23/26
Reprogramming cells inside the body: The regenerative medicine frontier moving from lab to clinic - Sep 23/26
Stem cell therapy eases Crohn’s disease by blocking iron-driven cell death - Sep 22/26
Base editors correct Artemis mutations, offering new hope for SCID gene therapy - Sep 22/26
Bone marrow transplants offer surprising way to treat mitochondrial disease, Stanford Medicine study shows - Sep 22/26
CAR T-cell therapy enables safe pregnancies in autoimmune patients - Sep 22/26
University of Alberta launches regenerative medicine hub at Life Sciences Week - Sep 22/26
Tumour slice cultures reveal new pitfalls in testing AAV gene therapy for glioblastoma - Sep 22/26
How the body keeps insulin-producing cells in check may shape future diabetes therapies - Sep 22/26
Lexeo takes up the Mantle in $8M acquisition for Friedreich ataxia assets - Sep 21/26
Researchers restored a lost CAR T target in thyroid cancer - Sep 21/26
Beacon’s XLRP gene therapy set for filing after phase 3 win - Sep 21/26
Natural killer cells stay battle-ready in obesity-linked cancer terrain - Sep 21/26
Mikhail, Davis on board with regulatory framework tailored to rare disease therapies - Sep 21/26
New study identifies genes that help flatworms regenerate their brains - Sep 20/26
Weekly reads: Longeveron MSC trial disappoints, CRISPR ancestor VIPR, distinct human brain progenitors, FDA staffing woes - Sep 17/26
Why you should measure comparability debt before ever starting a study - Sep 16/26
Canada must reclaim its reputation as a leader in diabetes innovation - Sep 16/26
The 2026 Ogawa-Yamanaka Stem Cell Prize awarded to Jun Takahashi - Sep 16/26
Amid patient deaths and adverse events Japan needs to tackle its unproven regenerative clinics - Sep 16/26
Pregnancy complications rare for women receiving CAR T-cell therapy - Sep 14/26
FDA approves first-in-human trial for dual-target CAR T therapy - Sep 14/26
UCLA scientists develop cancer-fighting cells that tumours struggle to escape - Sep 13/26
Weekly reads: suite of reprogramming news, cancer trial reform, zombie retracted papers - Sep 9/26
Cord blood stem cells support off-the-shelf TCR therapy development - Sep 9/26
The real cost of CAR T-cell therapy in myeloma - Sep 8/26
BrainChild Bio moves CAR-T into pivotal study for paediatric brain cancer - Sep 8/26
New review highlights promise of intra-arterial stem cell therapy to improve stroke recovery - Sep 8/26
UCLA scientists engineer ready-to-use cancer-fighting T cells for solid tumours - Sep 8/26
Two children died from gene therapies in China: where the field goes next - Sep 8/26
Tiny tumour-triggered patches turn immune cells into cancer fighters - Sep 7/26
Cell and gene therapy sector gains fresh backing as suppliers scale-up capacity - Sep 4/26
Engineering a kinase-controlled allosteric switch for improved performance - Sep 3/26
Typewriter raises $56m Series A to progress non-viral gene therapy platform - Sep 3/26
Ultragenyx’s ‘high-risk’ Angelman bet fails, cratering stock and forcing strategic review - Sep 2/26
Ex-Samsung Biologics executive to co-lead Korea’s MEDIPOST - Sep 1/26
Novartis and BMS slam breaks on gene therapy trials after adverse events - Aug 31/26
This Week’s CGT News: Bristol Myers ends Cellares manufacturing agreement - Aug 31/26
UC San Diego researchers win DARPA award to develop improved red blood cells - Aug 31/26
Why retinal diseases could become the proving ground for the next generation of regenerative therapies - Aug 30/26
Canada needs to bolster its biomanufacturing capacity - Aug 30/26
Weekly reads: aging clocks under the gun, more on R3 Stem warning, Capricor update, FDA perinatal tissue setbackWeekly reads: aging clocks under the gun, more on R3 Stem warning, Capricor update, FDA perinatal tissue setback - Aug 29/26
Engineered Komagataella phaffii boosts full-length human type III collagen production - Aug 28/26
The secret identity of a cell cycle regulator in cells that don’t cycle - Aug 28/26
Study compares BBB-crossing AAV capsids for efficient central nervous system delivery - Aug 27/26
Unexpected discovery reveals mechanism behind brain tumour development - Aug 26/26
Big implications for clinic arena from FDA warning to R3 Stem Cell, David Greene, & associated firms - Aug 25/26
Alpha protein kinase 3 gene therapy restores heart function in cardiomyopathy models - Aug 25/26
First-in-human pilot trial for new sickle cell disease gene therapy approach proves quicker, more efficient than industry average - Aug 25/26
Two decades of induced pluripotent stem cells: From pluripotency to reprogramming - Aug 24/26
New hydrogel platform simplifies the creation of living tissue models - Aug 24/26
Safety concerns spur FDA to again halt testing of Regenxbio gene therapy - Aug 23/26
Weekly reads: Heidi Overton FDA commish nominee, NASA stem cells, aged brain organoids, cautious Nature iPS cell editorial - Aug 20/26
Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa - Aug 20/26
The BioPharm Brief: Rare Disease, New Options - Aug 19/26
3D-printed spheroids support the regeneration of bone tissue - Aug 19/26
Red blood cells inspire next-generation therapeutic nanocarriers - Aug 18/26
Red blood cell-inspired carriers show promise for gene therapy delivery - Aug 18/26
Researchers develop invisible cell armour for safer diabetes treatment - Aug 18/26
Spatial biology in infectious disease and emerging fields - Aug 17/26
After two undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted? - Aug 17/26
Dongguk University researchers develop innovative electromagnetically controllable gene switch - Aug 17/26
Red blood ells inspire next-generation nanocarriers for targeted therapies - Aug 17/26
New imaging technology tracks cancer from the whole body to single cells - Aug 17/26
This Week’s CGT News: T-cell therapy clears pediatric solid tumour - Aug 15/26
DUSP4 boosts antitumour CD8+ T cells, CAR-T efficacy in colorectal cancer mice - Aug 14/26
First human trials of designer protein therapies stun US neuroscientists - Aug 14/26
Fate Therapeutics initiates potentially registrational trial of off-the-shelf CAR T-cell therapy FT819 for lupus nephritis - Aug 14/26
A genomics library for the AI era - Aug 14/26
Cell ‘invisibility cloaks’ could offer side-effect-free diabetes treatment - Aug 13/26
Meis2 gene identified as potential therapeutic target for neurodevelopmental disorders
- Oct 2/26
-
